Cardiac Events, Mortality and Hospitalization Reduced
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Mesoblast
- Positive Heart Failure Trial Results Presented to AHA
- MSB and Lonza form strategic global manufacturing alliance
- Licensing Executives Society Deals of Distinction Award
- Intervertebral Disc Repair Phase 2 Trial Update
- First Minimally Invasive Procedure for Lumbar Disc Repair
Later from Mesoblast
- Appendix 4C and Clinical Trial Update
- Mesoblast Clear To Proceed With Angioblast Acquisition
- Mesoblast Targets Broader Cancer Indications
- Novel Heart Attack Treatment Results Presented to US Forum
- On Track for Phase 3 BMT Trial After Positive FDA Meeting
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast